↓ Skip to main content

Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses

Overview of attention for article published in Journal for Immunotherapy of Cancer, January 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
patent
1 patent

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses
Published in
Journal for Immunotherapy of Cancer, January 2019
DOI 10.1186/s40425-019-0497-0
Pubmed ID
Authors

S. J. Santegoets, C. L. Duurland, E. S. Jordanova, J. J. van Ham, I. Ehsan, S. L. van Egmond, M. J. P. Welters, S. H. van der Burg

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 32%
Student > Master 6 15%
Researcher 4 10%
Other 3 7%
Student > Doctoral Student 2 5%
Other 5 12%
Unknown 8 20%
Readers by discipline Count As %
Medicine and Dentistry 11 27%
Immunology and Microbiology 9 22%
Agricultural and Biological Sciences 6 15%
Biochemistry, Genetics and Molecular Biology 5 12%
Business, Management and Accounting 1 2%
Other 1 2%
Unknown 8 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2023.
All research outputs
#7,051,839
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,697
of 3,424 outputs
Outputs of similar age
#138,566
of 446,775 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#57
of 83 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 3,424 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,775 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.